Heartflow (HTFL) closed at $46.69 on November 20, 2026, up 4.6% from the previous close, on volume of 1,787,779 shares (30-day average 1,629,637).
Data as of November 20, 2026.
20-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 20, 2026 | Diagonal Put Spread | 20-Nov : 18-Dec-2655 : 45 P | 8,376 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 20, 2026. See the largest for 5, 30, 60 and 90 days
J.P. Morgan Remains a Buy on HeartFlow, Inc. (HTFL)
TipRanks (Tue, 17-Nov 7:06 AM ET)
Heartflow Reports Third Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
Globe Newswire (Thu, 12-Nov 4:01 PM ET)
Globe Newswire (Mon, 2-Nov 8:00 AM ET)
Globe Newswire (Sun, 1-Nov 1:45 PM ET)
Boston Scientific announces results for third quarter 2026
PRNewswire (Wed, 28-Oct 6:31 AM ET)
Market Chameleon (Tue, 20-Oct 7:57 AM ET)
Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026
Globe Newswire (Mon, 19-Oct 4:01 PM ET)
Globe Newswire (Fri, 28-Aug 2:48 AM ET)
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference
Globe Newswire (Thu, 27-Aug 4:01 PM ET)
Heartflow’s Q2 Revenue Surges 48% as Annual Guidance Raised: Gross Margins Hit Record Highs
Market Chameleon (Fri, 14-Aug 6:31 AM ET)
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
Heartflow trades on the NASDAQ stock market under the symbol HTFL.
As of November 20, 2026, HTFL stock price climbed to $46.69 with 1,787,779 million shares trading.
HTFL has a beta of 1.10, meaning it tends to be more sensitive to market movements. HTFL has a correlation of 0.04 to the broad based SPY ETF.
HTFL has a market cap of $4.10 billion. This is considered a Mid Cap stock.
Last quarter Heartflow reported $73 million in Revenue and -$.03 earnings per share. This beat revenue expectation by $8 million and exceeded earnings estimates by $.09.
The top ETF exchange traded funds that HTFL belongs to (by Net Assets): VTI, VB, IWM, VBR, VXF.
HTFL has outperformed the market in the last year with a return of +68.7%, while the SPY ETF gained +6.9%. In the last 3 month period, HTFL beat the market returning -0.2%, while SPY returned -9.3%. However, in the most recent 2 weeks HTFL has underperformed the stock market by returning -10.9%, while SPY returned -6.2%.
HTFL support price is $42.54 and resistance is $46.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HTFL shares will trade within this expected range on the day.